# Serum IL 26 as a Marker of Disease Activity in SLE

> **NCT05161988** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 52 (estimated)

## Conditions studied

- SLE

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05161988
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-10
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161988, "Serum IL 26 as a Marker of Disease Activity in SLE". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05161988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*